Natco Pharma (BOM:524816) Days Sales Outstanding : 101.55 (As of Mar. 2024)

View and export this data going back to 1995. Start your Free Trial

What is Natco Pharma Days Sales Outstanding?

Natco Pharma's average Accounts Receivable for the three months ended in Mar. 2024 was ₹11,889 Mil. Natco Pharma's Revenue for the three months ended in Mar. 2024 was ₹10,683 Mil. Hence, Natco Pharma's Days Sales Outstanding for the three months ended in Mar. 2024 was 101.55.

The historical rank and industry rank for Natco Pharma's Days Sales Outstanding or its related term are showing as below:

BOM:524816' s Days Sales Outstanding Range Over the Past 10 Years
Min: 47.28 Med: 96.59 Max: 104.1
Current: 96.29

During the past 13 years, Natco Pharma's highest Days Sales Outstanding was 104.10. The lowest was 47.28. And the median was 96.59.

BOM:524816's Days Sales Outstanding is ranked worse than
53.41% of 996 companies
in the Drug Manufacturers industry
Industry Median: 72.035 vs BOM:524816: 96.29

Natco Pharma's Days Sales Outstanding increased from Mar. 2023 (87.00) to Mar. 2024 (101.55).

Natco Pharma Days Sales Outstanding Historical Data

The historical data trend for Natco Pharma's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Natco Pharma Days Sales Outstanding Chart

Natco Pharma Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Days Sales Outstanding

Get a 7-Day Free Trial

102.23

104.10

99.02

99.55

93.33

Natco Pharma Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Sales Outstanding	Get a 7-Day Free Trial															87.00	68.50	99.07	134.70	101.55

Competitive Comparison of Natco Pharma's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Natco Pharma's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Natco Pharma's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Natco Pharma's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Natco Pharma's Days Sales Outstanding falls into.

Natco Pharma Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Natco Pharma's Days Sales Outstanding for the fiscal year that ended in Mar. 2024 is calculated as

	Days Sales Outstanding (A: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Mar. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (8561	+	11889)	/	2 )	/	39988	*	365
=	10225					/	39988	*	365
=	93.33

Natco Pharma's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding (Q: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (0	+	11889)	/	1 )	/	10683	*	365 / 4
=	11889					/	10683	*	365 / 4
=	101.55

Natco Pharma (BOM:524816) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Natco Pharma Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Natco Pharma's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Natco Pharma (BOM:524816) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Natco Pharma Ltd (BOM:524816) » Definitions » Days Sales Outstanding

Traded in Other Exchanges

NATCOPHARM:India

Address

Road No. 2, NATCO House, Banjara Hills, Hyderabad, TG, IND, 500034

Website

https://www.natcopharma.co.in

Natco Pharma Ltd is a major drug manufacturing company. Natco aims to make specialty medicines accessible to all by manufacturing niche pharmaceutical products backed by its research and development capabilities. While the vast majority of the company's revenue is generated in India, the company looks internationally for growth opportunities. The company maintains a presence in Oncology and Hepatology treatment areas. Natco's active pharmaceutical ingredient segment APIs forms a core part of the company's business. The company operates in two different business segments: pharmaceuticals and agrochemicals. Within the pharma business segment, the company drives its sales through Finished Dosage Forms and Active Pharmaceutical Ingredients.

Natco Pharma (BOM:524816) Headlines

No Headlines